NCT04361240View on ClinicalTrials.gov

Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study

CompletedOBSERVATIONAL
Enrollment

172

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

May 29, 2025

Study Completion Date

May 29, 2025

Conditions
Breast CancerCardiotoxicity
Interventions
RADIATION

Proton vs Photon Radiation

Assignment to proton vs photon by randomization on RadComp parent study.

Trial Locations (6)

10065

Memorial Sloan Kettering Cancer Center, New York

19104

Abramson Cancer Center at University of Pennsylvania, Philadelphia

21287

Johns Hopkins, Baltimore

35233

University of Alabama, Birmingham

60555

Northwestern Medicine, Warrenville

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT04361240 - Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study | Biotech Hunter | Biotech Hunter